Showing results (61-70 of 77) with videos related to
Sort By:
Pageof 8
Frontiers in Endocrinology|May 16, 2022
Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes MellitusYuichiro Iwamoto, Tomohiko Kimura, Fuminori Tatsumi, et al.Journal of Diabetes Investigation|February 19, 2021
Effects of sedentary behavior and daily walking steps on body mass index and body composition: Prospective observational study using outpatient clinical data of Japanese patients with type 2 diabetesShuhei Nakanishi, Masashi Shimoda, Fuminori Tatsumi, et al.Frontiers in Endocrinology|May 31, 2022
Effect of Hyperglycemia-Related Acute Metabolic Disturbance on Thyroid Function Parameters in AdultsYuichiro Iwamoto, Tomohiko Kimura, Fuminori Tatsumi, et al.Scientific Reports|October 13, 2022
Association between changes in pancreatic morphology and vascular complications in subjects with type 2 diabetes mellitus: a retrospective studyYuichiro Iwamoto, Tomohiko Kimura, Fuminori Tatsumi, et al.Diabetes Research and Clinical Practice|August 9, 2019
Comparison of HbA1c levels and body mass index for prevention of diabetic kidney disease: A retrospective longitudinal study using outpatient clinical data in Japanese patients with type 2 diabetes mellitusShuhei Nakanishi, Hidenori Hirukawa, Masashi Shimoda, et al.Internal Medicine (Tokyo, Japan)|August 4, 2017
Werner Syndrome and Diabetes Mellitus Accompanied by Adrenal Cortex CancerMomoyo Nishioka, Shinji Kamei, Tomoe Kinoshita, et al.Lipids in Health and Disease|February 2, 2019
Eicosapentaenoic acid/arachidonic acid ratio and weight loss during hospitalization for glycemic control among overweight Japanese patients with type 2 diabetes: a retrospective observational studyShuhei Nakanishi, Hidenori Hirukawa, Masashi Shimoda, et al.Internal Medicine (Tokyo, Japan)|May 16, 2018
Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective AnalysisShuhei Nakanishi, Masahiro Iwamoto, Shinji Kamei, et al.Journal of Diabetes Investigation|April 25, 2020
Comparison of the effects of three kinds of glucose-lowering drugs on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open-label, three-arm, active control studyTomoe Kinoshita, Masashi Shimoda, Koji Nakashima, et al.Journal of Diabetes Investigation|July 28, 2025
A clinical model for highly accurate prediction of blood glucose depression after continuous intravenous insulin therapy in hyperglycemic emergencies, a multicenter retrospective cohort studyYuichiro Iwamoto, Tomohiko Kimura, Masashi Shimoda, et al.Pageof 8